Biomark Diagnostics Inc. reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was CAD 0.039746 million compared to CAD 0.0359 million a year ago. Net loss was CAD 0.418855 million compared to CAD 0.419141 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.173 EUR | -4.42% | -4.42% | +17.69% |
1st Jan change | Capi. | |
---|---|---|
+17.69% | 17.63M | |
-19.78% | 10.81B | |
+44.90% | 3.36B | |
-33.46% | 2.22B | |
-14.31% | 2.16B | |
-28.86% | 1.55B | |
+25.34% | 1.04B | |
-3.28% | 746M | |
-35.33% | 425M | |
-46.53% | 405M |
- Stock Market
- Equities
- 20B Stock
- News Biomark Diagnostics Inc.
- Biomark Diagnostics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023